Dr Rebecca Lawrence
Professional Title: CEO/Managing Director/Chief Executive
Primary domain: Life Sciences
Organization name: F1000 Group
Organization type: Small and Medium Enterprise
City / Country: London - United Kingdom
Rebecca Lawrence is Managing Director of F1000, providers of a series of tools and services to support the research community in writing, publishing, discovering and evaluating new scientific findings. She was responsible for the launch of the novel open science publishing platform F1000Research. She has subsequently led the initiative behind the recent launches of Wellcome Open Research, Gates Open Research, and many other funder- and institution-based publishing platforms that aim to start a new trajectory in the way scientific findings and data are communicated and ultimately research and researchers are evaluated. She is a member of the High-Level Advisory Group for the EC’s Open Science Policy Platform, chairing their work on next-generation indicators and their integrated advice: OSPP-REC. She has been a co-Chair of a number working groups focussing on data and peer review, for organisations including the RDA, CASRAI and ORCID. She is also an Advisory Board member for the data policy and standards initiative, FAIRsharing, and for DORA (the San Francisco Declaration on Research Assessment). She has worked in STM publishing for almost 20 years for several publishers including Elsevier where she built and ran the Drug Discovery Group. She originally trained and qualified as a pharmacist, and holds a PhD in Cardiovascular Pharmacology.